154 related articles for article (PubMed ID: 37642049)
21. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
[TBL] [Abstract][Full Text] [Related]
22. Stage IVA cervical cancer: outcomes of disease related complications and treatment.
Khulpateea BR; Paulson A; Carlson M; Miller DS; Lea J
Int J Gynecol Cancer; 2021 Apr; 31(4):518-523. PubMed ID: 32920534
[TBL] [Abstract][Full Text] [Related]
23. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
24. The challenging management of malignant ureteral obstruction: Analysis of a series of 188 cases.
Artiles Medina A; Laso García I; González Tello F; Álvarez Rodríguez S; Hevia Palacios M; Mata Alcaraz M; Mínguez Ojeda C; Arias Funez F; Gómez Dos Santos V; Burgos Revilla FJ
Curr Urol; 2024 Mar; 18(1):34-42. PubMed ID: 38505156
[TBL] [Abstract][Full Text] [Related]
25. Impact of hydronephrosis and kidney function on survival in newly diagnosed advanced cervical cancer.
Damian FB; de Almeida FK; Fernandes FS; Jimenez MF
Gynecol Oncol Rep; 2022 Feb; 39():100934. PubMed ID: 35128019
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of locally advanced cervical cancer presenting with obstructive uropathy: An institutional audit.
Salunkhe R; Chopra S; Kulkarni S; Shetty N; Engineer R; Mahantshetty U; Ghosh J; Gupta S; Shrivastava SK
Indian J Cancer; 2020; 57(4):416-422. PubMed ID: 33078748
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
28. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for overall survival in malignant ureteral obstruction.
Mason JB; Creswell M; Egan J; Dall C; Sholklapper T; Galloway LA; Orzel J; Lee H; Desale S; Stamatakis L
Can J Urol; 2022 Jun; 29(3):11162-11169. PubMed ID: 35691038
[TBL] [Abstract][Full Text] [Related]
30. [Internal urinary diversion in pelvic cancers and quality of life. Value of double "J" endoprosthesis].
Giannakopoulos X; Gartzios A; Giannakis D; Tsamboulas K; Kotoulas K
J Urol (Paris); 1995; 101(5-6):221-7. PubMed ID: 8761875
[TBL] [Abstract][Full Text] [Related]
31. Clinical course in patients with percutaneous nephrostomy for hydronephrosis associated with advanced cancer.
Tanaka T; Yanase M; Takatsuka K
Hinyokika Kiyo; 2004 Jul; 50(7):457-62. PubMed ID: 15334888
[TBL] [Abstract][Full Text] [Related]
32. [Hydronephrosis as a prognostic factor for patients of figo IIIB cervical cancer].
Krynicki R; Bidziński M; Wierzba W; Panek G; Jońska J; Lindner B
Ginekol Pol; 2003 Jan; 74(1):32-9. PubMed ID: 12715435
[TBL] [Abstract][Full Text] [Related]
33. Clinical Observation of Double Percutaneous Nephrostomy Combined with Ureter Occlusion Stent for Treating Cervical Cancer Complicated with Vesicovaginal Fistula.
Duan XH; Li FY; Han XW; Wu G; Zhang JH; Tian YD; Zhang YC
Cancer Biother Radiopharm; 2022 Nov; 37(9):759-765. PubMed ID: 33016777
[No Abstract] [Full Text] [Related]
34. Percutaneous nephrostomy in gynecologic oncology patients.
Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
[TBL] [Abstract][Full Text] [Related]
35. A misplacement of a ureteral stent into the abdominal aorta: a case report of a rare retrograde ureteral stenting complication.
Prijovic N; Cegar B; Cvetic V; Santric V; Stankovic B; Radojevic J
BMC Womens Health; 2022 Nov; 22(1):458. PubMed ID: 36401287
[TBL] [Abstract][Full Text] [Related]
36. Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without.
Fang C; Zhang P; Yu A; Yang Y; Zhang J
Gynecol Oncol; 2021 Jul; 162(1):50-55. PubMed ID: 33858676
[TBL] [Abstract][Full Text] [Related]
37. Management of acute hydronephrosis in pregnancy by ureteral stenting.
Zwergel T; Lindenmeir T; Wullich B
Eur Urol; 1996; 29(3):292-7. PubMed ID: 8740034
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
[TBL] [Abstract][Full Text] [Related]
39. Hydronephrosis after radical hysterectomy: a prospective study.
Suprasert P; Euathrongchit J; Suriyachai P; Srisomboon J
Asian Pac J Cancer Prev; 2009; 10(3):375-8. PubMed ID: 19640176
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with subcutaneous urinary diversion: new approach using a double pigtail stent.
Ahmadzadeh M
Br J Urol; 1991 Jun; 67(6):596-9. PubMed ID: 1712654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
